Results 171 to 180 of about 316,749 (274)

Head-to-head comparison of limus- versus paclitaxel-coated balloons in the treatment of in-stent restenosis: a meta-analysis. [PDF]

AsiaIntervention
Sagris M, Soulaidopoulos S, Ktenopoulos N, Papanikolaou A, Dimitriadis K, Patsourakos N, Tousoulis D, Scheller B, Colombo A, Tsioufis K.   +9 more
europepmc   +1 more source

Association between antiphospholipid antibodies, rheumatic-immune inflammation, and coronary in-stent restenosis. [PDF]

Front Cardiovasc Med
Mao W, Wu Z, Wei Y, Wang G, Xiong T, Chang P, Ye F.   +6 more
europepmc   +1 more source

A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial.

Journal of the American College of Cardiology, 2015
F. Alfonso, M. Pérez-Vizcayno, Alberto Cárdenas, B. García del Blanco, A. García-Touchard, J. López-Mínguez, A. Benedicto, M. Masotti, J. Zueco, A. Íñiguez, M. Velázquez, R. Moreno, V. Mainar, Antonio J Domínguez, F. Pomar, R. Melgares, F. Rivero, P. Jiménez-Quevedo, N. Gonzalo, C. Fernández, C. Macaya   +20 more
semanticscholar   +1 more source

Intravascular brachytherapy vs. drug-coated balloons for in-stent restenosis in patients with diabetes. [PDF]

Front Cardiovasc Med
Sella G, Gandelman G, Blatt A, George J, Abu Khadija H, Ayyad O, Olek D, Teh BS, Lin YY, Deva A, Kharsa C, Kritya M, Anwaar MF, Elias J, El Hajj E, Raizner AE, Farach A, Kleiman NS, Shah A.   +18 more
europepmc   +1 more source

Retrospective Analysis of In-Stent Restenosis in Diabetic Patients. [PDF]

Cureus
Khalid H, Mudassar H, Husnain A, Hayat MF, Baig BJ, Nazir A, Riaz H.   +6 more
europepmc   +1 more source

Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.

Circulation, 1999
R. Mehran, G. Dangas, Andrea Abizaid, G. Mintz, A. Lansky, L. Satler, A. Pichard, K. Kent, G. Stone, M. Leon   +9 more
semanticscholar   +1 more source

Immune dysregulation complicated by recurrent in-stent restenosis in patients with multivessel coronary artery disease: a case report. [PDF]

BMC Cardiovasc Disord
Jiang J, Huang Z, Li C, Zhang H, Zhao Z, Yang F, Gai Y, Li F, Gong C, Wu Y.   +9 more
europepmc   +1 more source

Remnant Cholesterol as a Predictor of Target-Vessel Failure in Patients With In-Stent Restenosis. [PDF]

Rev Cardiovasc Med
Kong XH, Lv ZH, Wang YF, Sun YD, Xu T, You W, Meng PN, Wu XQ, Wu ZM, Jia HB, Ye F.   +10 more
europepmc   +1 more source

Inflammation and In-Stent Restenosis [PDF]

Angiology, 2017
openaire   +2 more sources

Reply to Letter to the Editor: "Comments on 'Evaluation of Whole Blood Viscosity to Predict Stent Restenosis'". [PDF]

Anatol J Cardiol
Çalapkulu Y.
europepmc   +1 more source